Acquisition History / Sun Pharmaceutical Industries / Organon & Co.
Sun Pharmaceutical Industries Acquires Organon & Co.
Announced April 27, 2026 — $11.75B
What happened
Organon is a Jersey City-based pharmaceutical company. Sun Pharma agreed on April 27, 2026 to acquire all of its outstanding shares for US$14.00 per share in cash, an all-cash transaction with an enterprise valuation of US$11.75B.
- Acquirer
- Sun Pharmaceutical Industries
- Target
- Organon & Co.
- Announced
- April 27, 2026
- Price
- $11.75B
- Industry
- Women's health and biosimilar pharmaceuticals
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Sun Pharmaceutical Industries acquire Organon & Co.?
Sun Pharmaceutical Industries acquired Organon & Co. on April 27, 2026. This was Sun Pharmaceutical Industries's 1st publicly tracked acquisition out of 1 we have on record.
How much did Sun Pharmaceutical Industries pay for Organon & Co.?
Sun Pharmaceutical Industries paid $11.75B for Organon & Co..
What does Organon & Co. do?
Organon is a Jersey City-based pharmaceutical company. Sun Pharma agreed on April 27, 2026 to acquire all of its outstanding shares for US$14.00 per share in cash, an all-cash transaction with an enterprise valuation of US$11.75B.
What other Women's health and biosimilar pharmaceuticals companies has Sun Pharmaceutical Industries acquired?
Organon & Co. is Sun Pharmaceutical Industries's only publicly tracked acquisition in Women's health and biosimilar pharmaceuticals so far.